Perrigo to Attend Upcoming Consumer Investor Conferences
Get Alerts PRGO Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 10.1%
Revenue Growth %: -4.7%
Join SI Premium – FREE
Separately, President and CEO,
Interested parties can access the Morgan Stanley webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.
About Perrigo
Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com.
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's investor meetings at the Jefferies Consumer Conference and the Morgan Stanley Consumer & Retail Conference will include certain "forward-looking statements" within the meaning of the Private Litigation Securities Reform Act of 1995, as amended. Forward-looking statements relate to future events and involve known and unknown risks, uncertainties and other factors—many of which beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended
View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-attend-upcoming-consumer-investor-conferences-301972791.html
SOURCE Perrigo Company plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
- Erasca proposes $500M common stock public offering
- Elong Power closes $6.6M public offering on Nasdaq
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Morgan Stanley, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share